➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Moodys
Merck
Baxter
Express Scripts

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Litigation Details for AbbVie Inc. v. Amgen Inc. (D. Del. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

AbbVie Inc. v. Amgen Inc. (D. Del. 2016)

Biologic Drugs cited in AbbVie Inc. v. Amgen Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for AbbVie Inc. v. Amgen Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-08-04 1 Composition 9,328,165 Purified Antibody Composition 8,231,876 Purified Antibody Composition 8,663,945 … U.S Patent No. 8,916,157; U.S Patent No. 8,961,973; U.S Patent No. 8,986,693; U.S Patent No. 9,096,666… U.S Patent No. 9,220,781; U.S Patent No. 9,272,041; U.S. Patent No. 9,359,434; and U.S. Patent No. 9,365,645…United States Patent and Trademark Office (“Patent Office”) has granted AbbVie numerous patents which are…of 6 patents each, and the patents-in-suit constitute the compilation of the two lists (2 patents were External link to document
2016-08-04 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,663,945; 8,911,964; 8,916,157… 28 September 2017 1:16-cv-00666 830 Patent None District Court, D. Delaware External link to document
2017-04-27 62 owner by assignment of U.S. Patent No. 8,663,945 (“the ’945 Patent”). AbbVie has alleged that … Non-Infringement and Invalidity of U.S. Patent No. 8,663,945 38. Amgen and AML… The ’945 Patent, the ’964 Patent, the ’157 Patent, the ’973 Patent, the ’693 Patent, the …the ’666 Patent, the ’781 Patent, the ’041 Patent, the ’434 Patent, and the ’645 Patent, and each of … the ’945 Patent, the ’964 Patent, the ’157 Patent, the ’973 Patent, the ’693 Patent, the ’666 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Boehringer Ingelheim
Express Scripts
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.